Anat Loewenstein (Anat Loewestein)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 29

Top Topics

Vascular Endothelial Growth Factor

Diabetic Retinopathy

Top Venues

Eye (London, England)

European journal of ophthalmology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Shulamit Schwartz, Nir Gomel, Anat Loewenstein, Adiel Barak
Use of a Novel Beyeonics One Three-dimensional Head-mounted Digital Visualization Platform in Vitreoretinal surgeries. European journal of ophthalmology (2024)
Federica Fossataro, Alfredo Pece, Giulio Maione, Dinah Zur, Anat Loewenstein
A rare case of simultaneous occurrence of non-arteritic anterior ischemic optic neuropathy and corpus callosum ischemia. European journal of ophthalmology (2024)
Federica Fossataro, Alfredo Pece, Giulio Maione, Dinah Zur, Anat Loewenstein
A rare case of simultaneous occurrence of non-arteritic anterior ischemic optic neuropathy and corpus callosum ischemia. European journal of ophthalmology 34 (4) (2024)
Ashish Sharma, Peter K Kaiser, Ramin Tadayoni, Frank G Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D Regillo, Kourous A Rezaei, Arshad M Khanani, Francesco Maria Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar Ns, Manisha Agarwal, Anat Loewenstein, Baruch D Kuppermann, null null
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (London, England) (2024)
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Maria Bandello, Anat Loewenstein, Baruch D Kuppermann
Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs. Eye (London, England) (2024)
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Maria Bandello, Anat Loewenstein, Baruch D Kuppermann
Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs. Eye (London, England) 38 (10) (2024)
Ashish Sharma, Taku Wakabayashi, Carl D Regillo, Chui Ming Gemmy Cheung, Anat Loewenstein, Dinah Zur, Dafna Goldberg, Assaf Hilely, Sengul Ozdek, Hüseyin Baran Özdemir, Nikulaa Parachuri, Nilesh Kumar, Baruch D Kuppermann, Francesco Maria Bandello, Francesca Amoroso
Subfoveal neurosensory detachment flattening and observe (SNF-Ob) approach for the management of Ci-DMO - a multicentric study. Eye (London, England) (2024)
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Maria Bandello, Anat Loewenstein, Baruch D Kuppermann
Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs. Eye (London, England) 38 (10) (2024)
Shulamit Schwartz, Nir Gomel, Anat Loewenstein, Adiel Barak
Use of a Novel Beyeonics One Three-dimensional Head-mounted Digital Visualization Platform in Vitreoretinal surgeries. European journal of ophthalmology 34 (3) (2024)
Ashish Sharma, Peter K Kaiser, Ramin Tadayoni, Frank G Holz, Luke Nicholson, Clara Vazquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D Regillo, Kourous A Rezaei, Arshad M Khanani, Francesco Maria Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Ram Dogra, Muralidhar Ns, Manisha Agarwal, Anat Loewenstein, Baruch D Kuppermann, null null
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI). Eye (London, England) (2024)
Carl J Danzig, Arshad M Khanani, Anat Loewenstein
C5 inhibitor avacincaptad pegol treatment for geographic atrophy: A comprehensive review. Immunotherapy (2024)
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Francesco Maria Bandello, Anat Loewenstein, Baruch D Kuppermann
Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs. Eye (London, England) 38 (10) (2024)
Maria Vittoria Cicinelli, Claudia Gerosolima, Pierluigi Scandale, Sarah Touhami, Dominika Pohlmann, Audrey Giocanti, Amir Rosenblatt, Anat Loewenstein, Francesco Maria Bandello, Elisabetta Miserocchi, null null
Clinical and imaging biomarkers of response to intravitreal dexamethasone implant in eyes with non-infectious uveitic macular oedema. Eye (London, England) (2023)
Anat Loewenstein, Alan Berger, Avril Daly, Catherine Creuzot-Garcher, Richard Gale, Federico Ricci, Javier Zarranz-Ventura, Robyn H Guymer
Correction: Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries. Eye (London, England) (2023)
Nir Sorkin, Eliya Levinger, Achiron Asaf, Nir Gomel, Shai Cohen, Gilad Rabina, Shulamit Schwartz, Adiel Barak, Anat Loewenstein, David Varssano
Use of a three-dimensional head-mounted digital visualization platform in cataract surgery. Eye (London, England) (2023)
Ashish Sharma, Anat Loewenstein, Nikulaa Parachuri, Nilesh Kumar, Alok Rasal, Francesco Maria Bandello, Baruch D Kuppermann
Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge? Eye (London, England) (2023)
Irina S Barequet, Amir Rosenblatt, Michal Schaap Fogler, Tamar Pedut-Kloizman, Dan Gaton, Anat Loewenstein, Zohar Habot-Wilner
Gender related trends among Israeli ophthalmologists professional career and personal life performance. Eye (London, England) (2023)
Ashish Sharma, Anat Loewenstein, Nikulaa Parachuri, Nilesh Kumar, Baruch D Kuppermann
Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases. Journal of vitreoretinal diseases 7 (6) (2023)
Anat Loewenstein, Alan Berger, Avril Daly, Catherine Creuzot-Garcher, Richard Gale, Federico Ricci, Javier Zarranz-Ventura, Robyn H Guymer
Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries. Eye (London, England) (2023)
Ashish Sharma, Anat Loewenstein, Nilesh Kumar, Nikulaa Parachuri, Francesco Maria Bandello, Baruch D Kuppermann
Aflibercept biosimilars - update on the development progress. Eye (London, England) (2023)
Daniele Veritti, Valentina Sarao, Jay Chhablani, Anat Loewenstein, Paolo Lanzetta, null null, null null
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2023)
David R Lally, Anat Loewenstein, Jennifer J Arnold, Yit C Yang, Kinfemichael Gedif, Catherine Best, Hersh Patel, Ramin Tadayoni, Jeffrey S Heier
Correction: Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies. Eye (London, England) (2022)
Ashish Sharma, Mineo Kondo, Chiharu Iwahashi, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello, Anat Loewenstein, Baruch D Kuppermann
Approved biosimilar ranibizumab-a global update. Eye (London, England) (2022)
Francine F Behar-Cohen, Anat Loewenstein
Current and Future Treatments for Diabetic Retinopathy. Pharmaceutics 14 (4) (2022)
David R Lally, Anat Loewenstein, Jennifer J Arnold, Yit C Yang, Kinfemichael Gedif, Catherine Best, Hersh Patel, Ramin Tadayoni, Jeffrey S Heier
Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies. Eye (London, England) (2022)
Varun Chaudhary, Gurkaran S Sarohia, Mark R Phillips, Daniel Park, Jim Xie, Dena Zeraatkar, Matthew Fung, Lehana Thabane, Anat Loewenstein, Frank G Holz, Sunir J Garg, Peter K Kaiser, Mohit Bhandari, Robyn H Guymer, Samantha Fraser-Bell, Sobha Sivaprasad, Charles C Wykoff
Role of anti-vascular endothelial growth factor in the management of non-proliferative diabetic retinopathy without centre-involving diabetic macular oedema: a meta-analysis of trials. Eye (London, England) (2022)
Matias Iglicki, Marina Khoury, Javier Ignacio Melamud, Lucas Donato, Adiel Barak, Diego Jose Quispe, Dinah Zur, Anat Loewenstein
Naïve subretinal haemorrhage due to neovascular age-related macular degeneration. pneumatic displacement, subretinal air, and tissue plasminogen activator: subretinal vs intravitreal aflibercept-the native study. Eye (London, England) (2022)
Mitta Pierre, Adam Mainguy, Irini P Chatziralli, Kaivon Pakzad-Vaezi, Jorge Ruiz-Medrano, Bahram Bodaghi, Anat Loewenstein, Jayakrishna Ambati, Marc D de Smet, Ramin Tadayoni, Sara Touhami
Macular Hemorrhage Due to Age-Related Macular Degeneration or Retinal Arterial Macroaneurysm: Predictive Factors of Surgical Outcome. Journal of clinical medicine 10 (24) (2021)
Irini P Chatziralli, Anat Loewenstein
Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature. Pharmaceutics 13 (8) (2021)